MDA GEN SA Sarah LeBaron von Baeyer, PhD · Variant Bio Concluding Recruitment for a Project on Metabolic Health in Tahiti We recently wrapped up recruitment for a genomic research study in Tahiti in partnership with Novo Nordisk and GHICL
HUM MDA GEN IM Iman Hamid · Variant Bio Paper on Faroese Ancestral History and Health Published in eLife We are thrilled to announce our latest paper published with the Faroe Genome (FarGen) project and the University of Copenhagen
MDA GEN LIF HI Hiba Babiker, PhD · Variant Bio Empowering Discovery Through a Type 2 Diabetes Study in South Asia Variant Bio recently launched a new study focused on diabetes in Bangladesh in partnership with Novo Nordisk and icddr,b
AI SCI BIO ECO MDA TCH GEN MED HUM SA Sarah LeBaron von Baeyer, PhD · Variant Bio Variant Bio’s CEO and Senior Director of Ethics Interviewed on NPR’s BioTech Nation Podcast This week on BioTech Nation, a weekly NPR segment hosted by the former NASA scientist and engineer Dr. Moira Gunn, CEO Andrew Farnum and I…
HUM MDA GEN JA Jaye Moors · Variant Bio Kicking Off a New Study on Metabolic Health with Cook Island Communities in Aotearoa New Zealand Variant Bio recently launched a study with Novo Nordisk, this time in partnership with the University of Otago and Pukapuka Community Group
SOC MDA GEN SPT SA Sarah LeBaron von Baeyer, PhD · Variant Bio Collaborating with Research Partners in South Africa on a Paper Published in Nature Communications We published an open-access article on how to apply flexible benefit-sharing models to genomic research projects in South Africa and beyond
MDA GEN HUM SA Sarah LeBaron von Baeyer, PhD · Variant Bio By the Wind of our Sails: Returning Study Results by Boat in New Caledonia An anthropologist and a geneticist from Variant Bio teamed up with partners in New Caledonia to return study results one island at a time
AI SOC GEN MED AN Andrew Farnum · Variant Bio Variant Bio Announces Partnership with Boehringer Ingelheim on New Kidney Targets Discovered with… Coinciding with our most recent pharma collaboration, we officially launched our Inference agentic AI platform and an accompanying website
HUM MDA GEN JA Jaye Moors · Variant Bio Project Launch in Samoa with Novo Nordisk and Oceania University of Medicine Variant Bio recently kicked off another new study with Novo Nordisk, this time in Samoa in partnership with Oceania University of Medicine
HUM MDA GEN LY Lyn Griffiths · Variant Bio Variant Bio Supports Cultural Initiatives in Norfolk Island through Unique Benefit-Sharing Program Prof. Lyn Griffiths from Queensland University of Technology visited Norfolk Island to check in on benefit-sharing initiatives
HUM MDA GEN SA Sarah LeBaron von Baeyer, PhD · Variant Bio Variant Bio’s Approach to Returning Research Results Featured in Trends in Genetics In our newest publication, we argue for the importance of tailoring research results according to cultural context and community input
SCI MDA GEN SA Sarah LeBaron von Baeyer, PhD · Variant Bio Variant Bio Team Members Join Partners from MRIN to Return Research Results in Indonesia We recently joined the team from the Mochtar Riady Institute for Nanotechnology to share research results with communities in Java and Bali
SCI ECO GEN MED DA David Purdy · Variant Bio Spotlight on R&D: Inside the World of DMPK The importance of optimizing compounds’ design and determining the viability of drug candidates for use in humans
GEN HUM MDA GA Gabrielle Bertier · Variant Bio A Novel Finding in Colombia Could Unlock New Tools in the Fight Against Alzheimer’s Disease How a rare mutation in the APOE gene may protect against Alzheimer’s disease
GEN ST Stephane Castel · Variant Bio African-Enriched Genetic Variants Hold the Key to Treating High Cholesterol Cholesterol, the PCSK9 gene, and the importance of including people of diverse ancestry in genetic studies